Among phlebotomy-dependent patients with polycythemia vera, the addition of rusfertide to standard-of-care treatment resulted ...
Study met the primary endpoint, with a significantly higher proportion of clinical responders on rusfertide compared to placebo ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback